Get started
Author

Aeshah A. Awaji

Observed names: A.A. Awaji, AA Awaji, Aeshah A Awaji, Aeshah Ali A. Awaji, Aeshah Ali Ahmad Awaji, Awaji, Aeshah A.
Institution: University of Tabuk
ORCID: 0000-0002-6057-3973
Observed ORCID: 0000-0002-6057-3973
OpenAlex ID: A5002157695
RETRACTED: Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology
2022 · Md. Mominur Rahman, Shabana Bibi, et al. · Biomedicine & Pharmacotherapy · 166
PDF
Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges
2022 · Fouad Damiri, Nagavendra Kommineni, et al. · Pharmaceuticals · 154
PDF
MXene (Ti3C2Tx)-Embedded Nanocomposite Hydrogels for Biomedical Applications: A Review
2022 · Fouad Damiri, Md. Habibur Rahman, et al. · Materials · 92
PDF
The diagnostic accuracy of intraoperative frozen section biopsy for diagnosis of sentinel lymph node metastasis in breast cancer patients: a meta-analysis
2022 · Alaa Ahmed Elshanbary, Alaa Abdelsameia Awad, et al. · Environmental Science and Pollution Research · 24
PDF
Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach
2023 · Partha Biswas, Shabana Bibi, et al. · Molecules · 21
PDF
Serum long noncoding RNAs FAS-AS1 & PVT1 are novel biomarkers for systemic lupus erythematous
2020 · MA Ali, OG Shaker, et al. · British Journal of Biomedical Science · 20
RNA binding proteins (RBPs) on genetic stability and diseases
2025 · Abdullahi Tunde Aborode, Ohilebo Abdulateef Abass, et al. · Global Medical Genetics · 17
N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity
2024 · Aeshah A. Awaji, Waheed Ali Zaki El Zaloa, et al. · Bioorganic Chemistry · 15
Design, Synthesis, In Vitro, and In Silico Studies of New N5-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors
2023 · Waheed A. Zaki, Selwan M. El-Sayed, et al. · Pharmaceuticals · 15
PDF
The Influence of rs1859168 Polymorphism on Serum Expression of HOTTIP and Its Target miR-615-3p in Egyptian Patients with Breast Cancer
2021 · Omayma O. Abdelaleem, Olfat G. Shaker, et al. · Biomolecules · 15
PDF
Novel Benzimidazole‐1,2,3‐Triazole Hybrids: Synthesis, Dual Antimicrobial, Anticancer Activity, Mechanistic Insights, and Computational Studies
2025 · Moataz A. Soliman, Elsayed H. Eltamany, et al. · ChemistrySelect · 14
PDF
Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies
2024 · H.H. Rashwan, A.M. Taher, et al. · Pathology - Research and Practice · 14
Approaching COVID‐19 with epidemiological genomic surveillance and the sustainability of biodiversity informatics in Africa
2022 · Abdullahi Tunde Aborode, Helen Huang, et al. · Journal of Medical Virology · 11
PDF
Unraveling the Role of THRIL/miR-137 in Fine-Tuning the Immunological Transcriptional Loop STAT4/STAT6/GATA3 in Multiple Sclerosis: Implications on Neurological Complications and Disease Subtypes
2025 · Ghada Ayeldeen, Bahaa Mohammed Badr, et al. · ACS Chemical Neuroscience · 8
Predictive identification and design of potent inhibitors targeting resistance-inducing candidate genes from E. coli whole-genome sequences
2024 · Abdullahi Tunde Aborode, Neeraj Kumar, et al. · Frontiers in Bioinformatics · 8
In silico study of selected alkaloids as dual inhibitors of β- and γ-secretases for Alzheimer's disease
2025 · Isreal Ayobami Onifade, Haruna Isiyaku Umar, et al. · Journal of Alzheimer s Disease · 7
PDF
Bio-molecular Fe(III) and Zn(II) complexes stimulate the interplay between PI3K/AKT1/EGFR inhibition and induce autophagy and apoptosis in epidermal skin cell cancer
2024 · Aeshah A. Awaji, Heba W. Alhamdi, et al. · Journal of Inorganic Biochemistry · 7
In-silico discovery of Dipeptidyl Peptidase-4 inhibitors from African medicinal plants: Molecular docking, ADMET, dynamics simulation, and MM-GBSA analyses
2025 · Ishola Abeeb Akinwumi, Amgad M. Rabie, et al. · The Nucleus · 6
Discovery of potent anticancer tricarboxamide analogs linked to 1,2,3-triazole, promoting EGFR and VEGFR downregulation
2025 · Fawzia F. Albelwi, Adeeb Al Sheikh, et al. · New Journal of Chemistry · 6
LncRNA NEAT1 and miRNA 101 as potential diagnostic biomarkers in patients with alopecia areata
2024 · Randa Erfan, Olfat G. Shaker, et al. · Non-coding RNA Research · 5
Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies
2023 · Ahmed K. B. Aljohani, Waheed Ali Zaki El Zaloa, et al. · International Journal of Molecular Sciences · 5
PDF
Identification of key molecular pathways and genes in BRCA1 and BRCA2-mutant ovarian cancer: evidence from bioinformatics analysis
2024 · Aeshah A. Awaji, Abdulkadir Yusif Maigoro, et al. · Genome Instability & Disease · 4
Serum Circ‐ DLGAP4 and miR ‐9 as Potential Biomarkers in Pancreatic Cancer
2025 · Marwa A. Ali, Olfat G. Shaker, et al. · Journal of Clinical Laboratory Analysis · 3
PDF
Diacerein's antiproliferative effects alone and with 5-fluorouracil in an Ehrlich solid tumour model: Molecular docking, molecular dynamics Simulation studies, and experimental Verification
2025 · Mohamed S. Abdel-Maksoud, Renad Abdullah Alatawi, et al. · European Journal of Pharmacology · 3
Chemotherapeutic Activity of Imidazolium-Supported Pd(II) o-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu and FGFR2/FGF2 Axis Overexpression in Breast Cancer Cells
2023 · Aeshah A. Awaji, Moustafa A. Rizk, et al. · Pharmaceuticals · 3
PDF
Works count: 38
Citation count: 651
H-index: 12
I10-index: 13
Year
Topic
Type